Skip to main content
Equibles
SNDA logo

SNDA · Sonida Senior Living, Inc. · Metrics

Track SNDA — free

Use SNDA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SNDA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$32.80 -0.74 (-2.21%) At close · Oct 27 Q2 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$1.59B
Shares
48.05M
Volume · Oct 27 545.36K Avg daily vol (3M) 458.81K

SNDA metrics

84 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$32.80
Market cap
$1.59B

Price action

20 metrics
Price change (1W)
-4.6%
Price change (30D)
-12.8%
Price change (3M)
-23.8%
Price change (6M)
-13.2%
Price change (YTD)
+0.6%
Price change (1Y)
+25.4%
Trailing year
Price change (5Y)
+13.5%
52-week high
$43.07
52-week low
$25.53
Change from 52-week high
-23.8%
Change from 52-week low
+28.5%
Annualized volatility
37.5%
Annualized volatility (3M)
32.9%
Beta
0.3
RSI (14D)
25.8
Price vs SMA 50
-12.4%
Price vs SMA 200
-9.9%
Avg volume (3M)
458,806
Relative volume
1.2
Average dollar volume
$17.46M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
48.05M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
5.9×
reciprocal yield 16.9%
EV / EBITDA
18.3×
reciprocal yield 5.5%
EV / EBIT
30.2×
reciprocal yield 3.3%
P / sales
3.0×
reciprocal yield 33.1%
P / book
1.8
reciprocal yield 54.1%
FCF yield
-3.3%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-7.7%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
4.2×
reciprocal yield 23.6%
EV / revenue historical average (5Y)
3.8×
reciprocal yield 26.0%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-05
Last earnings
2026-08-10

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
-23.2%
Gross profit (TTM)
—
Operating profit (TTM)
$73.89M
Net income (TTM)
−$121.88M
Trailing 12 months
Diluted EPS (TTM)
$-6.20
FCF margin
-10.0%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$20.02
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$-5.23
Operating cash flow per diluted share (TTM)
$-0.57
Free cash flow per diluted share (TTM)
$-2.09
Capital expenditures per diluted share (TTM)
$1.52
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.30
Book value per share
$0.00

Growth

11 metrics
Revenue growth YoY
+122.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$525.97M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+158.7%
Year over year · more shares
Revenue CAGR (3Y)
+16.9%
Revenue CAGR (5Y)
-0.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-14.1%
Return on assets
-4.8%
Debt / equity
1.8
Current ratio
0.9
EBITDA (TTM)
$121.70M
Free cash flow (TTM)
−$52.71M
Quick ratio
0.9
Interest coverage
—
Net debt / EBITDA
5.2
Return on invested capital
—
Trailing 12 months
Net cash
−$1.52B
Latest balance sheet
Cash & equivalents
$48.71M
Total assets
$2.55B
Total debt
$1.57B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$15.56M
Capital expenditures (TTM)
$37.15M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$7.41M
R&D / revenue
—
Stock compensation / revenue
1.4%

Ownership (13F)

9 metrics
13F filers
229
13F filer change QoQ
0
Institutional ownership
77.7%
Conviction holders (share of 13F filers)
4.8%
Crowding (high-turnover and private-fund holders)
52.7%
Private-fund adviser ownership
52.4%
Active holders' share change QoQ
+26.9%
Holder tenure
10.6
Price vs estimated holder cost
+19.4%

Ownership (registered funds)

1 metrics
Index-fund ownership
5.9%

Short interest

3 metrics
Short interest
8.0%
Latest settlement · 7.6 days to cover
Days to cover
7.6d
Short-squeeze score
65 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$10.90M
Insider-sentiment score
12 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1043000 CUSIP 140475203 13F (30d) 34 filings 34 filers Visit website Investor relations